Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant

Bone Marrow Transplantation

Volumn 28, Issue 11, 2001, Pages 1031-1036

  Godder, K T ^a   Metha, J ^a   Chiang, K Y ^a   Adams, S ^a   Van Rhee, F ^a   Higgins Smith, K ^a   O'Neal W ^a   DeRienzo, S ^a   Henslee Downey, J P ^a  

^a South Carolina Cancer Center   (United States)

Author keywords

Autologous; BMT; Mismatched related donor; Relapsed AML; Second transplant

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LYMPHOCYTE DEPLETION; MALE; PARENT; PRIORITY JOURNAL; RECIPIENT; RESPIRATORY TRACT DISEASE; SALVAGE THERAPY; SIBLING; T LYMPHOCYTE; TREATMENT FAILURE; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOID; MALE; PROSPECTIVE STUDIES; RECURRENCE; SALVAGE THERAPY; SURVIVAL; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT FAILURE;

EID: 0035663390     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703279     Document Type: Article

References (26)

1. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia
2. Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia
3. Autologous bone marrow transplant in acute myeloid leukemia in first remission
4. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission
5. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: A prospective controlled trial
6. Response to salvage therapy and survival after relapse in acute myelogenous leukemia
7. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation
8. Outcome of acute leukemia relapsing after bone marrow transplantation: Utility of second transplants and adoptive immunotherapy
9. Donor search or autografting in patients with acute leukemia who lack an HLA-identical sibling? A matched pair analysis
10. Partially mismatched related donor transplants as salvage therapy for patients with refractory leukemia who relapse post-BMT
11. Use of partially mismatched related donors extends access to allogeneic marrow transplant
12. Rare failure to engraft following haploidentical T-cell depleted marrow transplantation using enhanced host immunoablation and OKT3 graft purging
13. Partially mismatched related donors allow for early allogeneic transplant intervention and improved disease free survival in young patients with poor prognosis acute leukemia
14. Use of a closed system for V αβ-positive T-cell depletion of marrow for use in partially mismatched related donor transplantation
15. Comparison of engraftment and acute GvHD following transplantation of partially mismatched grafts T cell depleted with OKT3 or T10B9 monoclonal antibody
16. Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation
17. Pre-emptive therapy with donor leukocyte infusions to prevent relapse following partially mismatched related donor bone marrow transplantation
18. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens
19. Second transplants for leukemic relapse after bone marrow transplantation: High early mortality but favorable effect of chronic GVHD on continued remission
20. Second HLA-identical sibling transplants for leukemia recurrence
21. Relapse of leukemia after bone marrow transplantation: Effect of second myeloablative therapy
22. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors
23. Comparison of immune reconstitution after related and related T-cell depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusion
24. Second allogeneic transplantation after failure of first autologous transplantation
25. Second allogeneic bone marrow transplantation in acute leukemia: A multicenter study from the Gruppo Italiano Trapianto Di Modollo Osseo (GITMO)
26. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse